Pediatric Acute Respiratory Distress Syndrome Asia Study
NCT ID: NCT04068038
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
738 participants
OBSERVATIONAL
2019-08-01
2024-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pediatric Acute Respiratory Distress Syndrome Ventilation Bundle
NCT03504176
Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial
NCT07123961
Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome
NCT04113434
Short Term Outcomes of Children With Acute Respiratory Distress Syndrome
NCT00142376
Paediatric Ards Neuromuscular Blockade Study
NCT02902055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ventilation protocol
An evidence based ventilation protocol will be implemented at participating sites. This will include limits on peak inspiratory pressure (28cmH2O), driving pressure (16cmH2O), tidal volume (mild 8ml/kg, mod/severe 6ml/kg), positive end expiratory pressure to fraction of inspired oxygen table, permissive hypercarbia (mild allow pH 7.30, mod/severe allow pH 7.20) and permissive hypoxia (mild SpO2 92-97%, mod/severe SpO2 88-92%).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* High flow nasal cannula
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Chongqing Medical University
OTHER
Guangzhou Women and Children's Medical Center
OTHER
Shengjing Hospital
OTHER
Children's Hospital of Fudan University
OTHER
Hong Kong Children's Hospital
OTHER
Sarawak General Hospital
OTHER
Universiti Kebangsaan Malaysia Medical Centre
OTHER
University of Malaya
OTHER
King Chulalongkorn Memorial Hospital
OTHER
Siriraj Hospital
OTHER
Ramathibodi Hospital
OTHER
National Children's Hospital, Vietnam
OTHER
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER
Rumah Sakit Anak dan Bunda Harapan Kita
UNKNOWN
Sanglah General Hospital
OTHER
General Hospital of North Sumatera University
UNKNOWN
Hyogo Prefectural Kobe Children's Hospital
OTHER
Aga Khan University
OTHER
National University Hospital, Singapore
OTHER
Singapore Clinical Research Institute
OTHER
KK Women's and Children's Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Judith Wong Ju-Ming
Consultant Pediatric Critical Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Judith Ju Ming Wong
Role: PRINCIPAL_INVESTIGATOR
KK Women's and Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangzhou Women and Children's Medical Center
Guangzhou, Guangzhou, China
Shengjing hospital of China Medical University
Shenyang, Liaoning, China
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Chongqing Hospital
Chongqing, Sichuan, China
Hong Kong Children's Hospital
Kowloon Bay, Kowloon, Hong Kong
Post Graduate Institute of Medical Education and Research
Chandigarh, , India
Sanglah Hospital Denpasar
Denpasar, Bali, Indonesia
Harapan Kita Children and Women hospital
Jakarta, , Indonesia
Hyogo Prefectural Kobe Children's Hospital
Hyōgo, Kobe, Japan
Universiti Kebangsaan Malaysia Medical Centre
Bandar Tun Razak, Kuala Lumpur, Malaysia
Sarawak General Hospital
Kuching, Sarawak, Malaysia
University Malaya Medical Centre
Kuala Lumpur, , Malaysia
Aga Khan University Hospital
Karachi, , Pakistan
KK Women's and Children's Hospital
Singapore, , Singapore
National University Hospital, Singapore
Singapore, , Singapore
Siriraj Hospital
Bangkok Noi, Bangkok, Thailand
King Chulalongkorn Memorial Hospital
Bangkok, , Thailand
Ramathibodi hospital
Bangkok, , Thailand
National Hospital of Pediatrics
Đống Đa, Hanoi, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wong JJM, Dang H, Gan CS, Phan PH, Kurosawa H, Aoki K, Lee SW, Ong JSM, Fan LJ, Tai CW, Chuah SL, Lee PC, Chor YK, Ngu L, Anantasit N, Liu C, Xu W, Wati DK, Gede SIB, Jayashree M, Liauw F, Pon KM, Huang L, Chong JY, Zhu X, Hon KLE, Leung KKY, Samransamruajkit R, Cheung YB, Lee JH; Pediatric Acute & Critical Care Medicine Asian Network (PACCMAN). Lung-Protective Ventilation for Pediatric Acute Respiratory Distress Syndrome: A Nonrandomized Controlled Trial. Crit Care Med. 2024 Oct 1;52(10):1602-1611. doi: 10.1097/CCM.0000000000006357. Epub 2024 Jun 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/3076(2)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.